Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01399307 · ClinicalTrials.gov registry record · NA
Extraction of Stromal Vascular Fraction and Stem Cells From Fat Tissue
A NA study of Soft Tissue Mass Removal, sponsored by Antria.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 2
- Study locations
NCT01399307: Completed NA study of Soft Tissue Mass Removal, sponsored by Antria.
NCT01399307 is a NA study of Soft Tissue Mass Removal that has completed, run by Antria. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01399307, a NA study of Soft Tissue Mass Removal, has completed, sponsored by Antria.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 2
- Study locations
Study Summary
Human Adipose Tissue is considered as a new source for Stromal Stem Cells and offers a large therapeutic potential for many rare and common diseases that impacts millions of patients worldwide. The Stromal Vascular Fraction (SVF) of Adipose Tissue is relatively easy to extract with minimally invasive procedures such as elective liposuction in large quantities and therefore may be a cost effective source for cellular therapies in a wide range of medical specialties. In this study we aim to demonstrate the efficacy of Antria Cell Preparation Process© in obtaining human adipose derived Stromal Vascular Fraction (SVF) by performing histology, various cell counts, multiple surface marker tests and measurement of the residual amount of digestive enzymes as a safety measure for human clinical trials.
Conditions Studied
Interventions
- PROCEDURE Liposuction
Study Locations (2)
Pennsylvania
- Blair Plastic Surgery - Altoona
- Indiana Regional Medical Center - Indiana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-08 |
| Phase | NA |
What the finished NCT01399307 record still lists
NCT01399307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Soft Tissue Mass Removal appearing as the primary indexed condition, and to 1 intervention - of which Liposuction is the first listed.
NCT01399307 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01399307 about?
NCT01399307 is a clinical study titled "Extraction of Stromal Vascular Fraction and Stem Cells From Fat Tissue". Human Adipose Tissue is considered as a new source for Stromal Stem Cells and offers a large therapeutic potential for many rare and common diseases that impacts millions of patients worldwide. The Stromal Vascular Fraction (SVF) of Adipose Tissue is relatively easy to extract with minimally invasiv...
What is the current status of trial NCT01399307?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2011-07. Estimated completion is 2011-08.
What conditions does trial NCT01399307 study?
This clinical trial studies the following conditions: Soft Tissue Mass Removal.
What interventions are being tested in trial NCT01399307?
The interventions under investigation include: Liposuction (PROCEDURE).
Who is sponsoring clinical trial NCT01399307?
This trial is sponsored by Antria, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01399307 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01399307's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia